Updates to SME Instrument Phase II Summer 2019

Updates to SME Instrument Phase II Summer 2019

New updates for SME Instrument Phase II are now available. We have summarized the most important information below.

Starting this summer, for the upcoming 9 October deadline, SME Instrument Phase 2 will offer an additional option to apply for. Currently, the grant consists of €2.5M. This summer, the additional option (blended finance) will combine the grant (€2.5M) with an equity investment from the European Commission (maximum €15M). This option is intended for early-stage and mature innovations for scale-up purposes. There is a total budget available of €100M for equity, within the 2019-2020 pilot phase.

For more information and the full call texts visit the website of EC

 

Press Release- Catalyzing Biohealth: New Transatlantic Partnership Focused on Expanding Resources for BioHealth Technology Commercialization

Press Release- Catalyzing Biohealth: New Transatlantic Partnership Focused on Expanding Resources for BioHealth Technology Commercialization

Catalyze and BioHealth Innovation announce transatlantic partnership Amsterdam and Rockville, Maryland 5 June 2019 Catalyze and BioHealth Innovation, Inc. have entered an agreement to actively bridge the Life Sciences communities in the US and the EU. This transatlantic partnership will increase opportunities for translating biohealth discoveries to market through grant writing services, expanded technology commercialization… Continue Reading

Radiobotics – Celebrating ranking as a top project with Eurostars

Radiobotics – Celebrating ranking as a top project with Eurostars

An interview with Stine Mølgaard Sørensen, Co-founder and COO of Radiobotics  Eurostars saw the potential of Radiobotics AI in X-ray screening to entirely disrupt the radiology world. They achieved their top-ranking position with Eurostars by making routine musculoskeletal radiology and diagnostics more efficient with their breakthrough AI technology, effectively improving the quality and freeing up… Continue Reading

Preventicus – Stroke prevention starts at the touch of your fingertips

Preventicus – Stroke prevention starts at the touch of your fingertips

Interview with Dr. Thomas Huebner, Founder and Managing Director of Preventicus GmbH. Following their success in securing an SME Instrument Phase II grant, Dr. Thomas Huebner sat down with us to tell us the story of how Preventicus and Health Tech are enabling us, and our doctors, with greater power over our healthcare decisions, and… Continue Reading

ZonMw and Zorginstituut Nederland release “Veelbelovende Zorg” subsidy for research and care of medical innovations to be allowed in the standard care package

ZonMw and Zorginstituut Nederland release “Veelbelovende Zorg” subsidy for research and care of medical innovations to be allowed in the standard care package

25-02-2019 Last week Catalyze attended the information day for the new call “Veelbelovende Zorg”, tender released by a collaboration of ZonMW and ZIN. This tender is the next program following on the “Voorwaardelijk Toelating”. The aim of the tender is to assist in the uptake of medical technologies and medication in the reimbursement model for… Continue Reading

Labonovum – simplifying laboratory analysis for patients

Labonovum – simplifying laboratory analysis for patients

Interview with Dennis Poland, Chief Innovation Officer (CIO) of Labonovum novum (plural novums or nova) A new feature, a novelty. Despite great advancements in clinical analysis laboratory for the past half century, not much has changed for patients – who still have to endure the same procedures to collect blood for analysis. Labonovum has recently been awarded €3 million with… Continue Reading

Press Release: iPSpine Kick-off Meeting

Press Release: iPSpine Kick-off Meeting

Amsterdam, 13 February 2019 On February 12th and 13th, the kick-off of an international, 15-million-euro, 20-partner project titled iPSpine (Induced pluripotent stem cell-based therapy for spinal regeneration) was held in Utrecht, The Netherlands. This 5-year project falls under the European Union’s Horizon 2020 programme to fund research that improves knowledge, testing, and exploitation platforms that address… Continue Reading

Catalyze and Health Valley announce strategic partnership to bring innovations to patients faster

Catalyze and Health Valley announce strategic partnership to bring innovations to patients faster

Amsterdam, 30 January 2019 Catalyze – a market leader in obtaining funding for life science innovations – joins forces with the healthcare innovation network Health Valley, in a strategic partnership aimed at bringing innovations to patients faster. Health Valley is the largest network of healthcare innovations in the Netherlands. Within the Health Valley network, companies,… Continue Reading

Accelerating Swiss innovations to market with strategic collaboration

Accelerating Swiss innovations to market with strategic collaboration

Amsterdam, 29 January 2019 Catalyze announces collaboration with Biopôle, providing dedicated services to members towards better access to non-dilutive funding opportunities. Catalyze is an expert in obtaining non-dilutive funding for life science innovations. Catalyze provides clients and partners with the necessary help in obtaining funding for their R&D projects, supporting them as well with services… Continue Reading

iPSpine – the veterinarian trying to solve the problem of low back pain

iPSpine – the veterinarian trying to solve the problem of low back pain

Interview with Professor Marianna Tryfonidou, from the Faculty of Veterinary Medicine of the Utrecht University The iPSpine project was recently awarded €15 million under the Horizon 2020 programme, towards researching a solution for chronic lower back pain. The huge public-private consortium is comprised of 20 partners, and is coordinated by the Faculty of Veterinary Medicine… Continue Reading

Added value Catalyze

Why choose Catalyze?


Scientific & academic

experts

Team of consultants with scientific and academic excellence (PhD, MD)

Commercial

experts

Consultants with experience in translating research into commercial products

Life sciences

biotechnology

Specialized in life sciences, biotechnology and medical technology.

Strong

network

Strong network of reliable and professional partners in the field.